Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 0.26 GBp
Change Today +0.05 / 24.39%
Volume 14.9M
EVO On Other Exchanges
As of 11:30 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

evocutis plc (EVO) Snapshot

0.21 GBp
Previous Close
0.21 GBp
Day High
0.26 GBp
Day Low
0.21 GBp
52 Week High
09/1/14 - 1.29 GBp
52 Week Low
08/20/14 - 0.16 GBp
Market Cap
Average Volume 10 Days
-0.0008 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for EVOCUTIS PLC (EVO)

Related News

No related news articles were found.

evocutis plc (EVO) Related Businessweek News

No Related Businessweek News Found

evocutis plc (EVO) Details

Evocutis plc does not have significant operations. The company intends to invest in and/or acquire companies and/or projects within the natural resources sector. Previously, it engaged in the provision of skin microbiology and clinical dermatology services to companies in the pharmaceutical and consumer healthcare markets. The company was formerly known as Syntopix Group plc and changed its name to Evocutis plc in October 2011. Evocutis plc was incorporated in 2005 and is based in London, the United Kingdom. As of March 19, 2014, Evocutis plc operates as a subsidiary of Venn Life Sciences Holding plc.

4 Employees
Last Reported Date: 01/21/15
Founded in 2005

evocutis plc (EVO) Top Compensated Officers

Interim Chief Executive Officer
Total Annual Compensation: 45.0K GBP
Chief Financial Officer and Group Finance Dir...
Total Annual Compensation: 3.0K GBP
Compensation as of Fiscal Year 2014.

evocutis plc (EVO) Key Developments

Evocutis plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended January 31, 2014

Evocutis plc announced unaudited consolidated earnings results for the six months ended January 31, 2014. For the year, the company reported loss before taxation was £57,000 against £67,000 a year ago. Loss for the period from continuing operations was £57,000 against £67,000 a year ago. Loss for the period and total comprehensive loss attributable to equity shareholders was £62,000 against £422,000 a year ago. Basic and diluted loss per ordinary share from continuing operations was 0.01 pence against 0.04 pence a year ago. Net cash flows used in operating activities was £303,000 against £387,000 a year ago. Payment to acquire intangible assets was £164,000.

Evocutis plc, Board Meeting, Mar 18, 2015

Evocutis plc, Board Meeting, Mar 18, 2015. Agenda: To approve the director's annual report; to approve the resignation of 3 directors; to approve the remuneration for directors for the year 2015; to approve the appointment of auditors; to approve the recapitalization of the company by issuing new shares offered to existing shareholders and private placement; to amend the company's Memorandum of Association in accordance with the capital restructuring of companies; and to approve the determination of the date for 2015 Annual General Meeting of Shareholders to be on April 30, 2015.

Evocutis plc Provides Update on Tungsten Mining Operations, Brazil

Evocutis Plc announced the completion of a NI 43-101 Technical Report compiled by Micon International Co Limited and an operations update for the Bodó Tungsten Mine in Brazil, which indicates that significant near and long term potential exists to expand mining operations. Evocutis is in the process of acquiring an initial 10% interest. Micon International Co Limited have completed a NI 43-101 Technical Report on the Bodó Tungsten Project, Rio Grande Do Norte, Brazil for Brazil Tungsten Holdings Limited that concluded that: High priority potential mineral resources total 112,000 tonnes grading 0.7-1.0% WO3 for between 82,900-116,400 mtu of contained WO3. Medium term targets for exploration and development have a potential resource of 239,250 tonnes grading 0.7-1.0% WO3 for between 167,000-239,000 mtu of contained WO3. The exploration potential of the Brazil Tungsten mineral licence areas is significant, and has the potential to host an exploration target in the range of two to three million tonnes. The Bodó mine is currently operating at approximately 50-60 tonnes of ore per day from the Pajeù incline Shaft on a 6 day per week operation. The last shipment of tungsten concentrate from Bodó was on the 5th January 2015 with estimated gross proceeds from this shipment of $150,000. At an APT Price of $290/mtu, this translates into a gross sale value per tonne of standard export concentrate containing 68% WO3 of approximately $15,000/tonne. The second mining area at Bodó, the Central incline Shaft, located about 400 metres from the current mining operations is currently being re-furbished and first ore is scheduled for delivery from Central Shaft to the mill in mid-February. BTHL envisages that the Central Shaft will quickly double overall Bodóproduction to about 100 tonnes per day of tungsten ore to the mill by the end of March. Unexplored exploration targets have been identified during the current work within the area of the mine workings. Development of these targets should yield tungsten resources for immediate development. The exploration potential of the Brazil Tungsten mineral licence areas is significant. The licence boundaries of Bodó and Tarantula include areas of 1.89 km2 and 99.65 km2, respectively, and have the potential to host an exploration target in the range of two to three million tonnes. This is considering that marble, calcsilicate and granitic rocks are known to exist at least 350 m down dip of the Bodó workings, combined with the undeveloped mineral potential at Tarantula. However, the current lack of geological mapping and understanding of the ore controls determines that these represent exploration targets rather than estimated resources.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVO:LN 0.26 GBp +0.05

EVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EVO.
View Industry Companies

Industry Analysis


Industry Average

Valuation EVO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOCUTIS PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at